258
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from grupo argentino de mieloma múltiple

, , , , , , , , , , , , , & show all
Pages 315-322 | Received 02 Sep 2020, Accepted 02 Feb 2021, Published online: 01 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rafael Ríos-Tamayo, Juan Alfons Soler, Ricarda García-Sánchez, Ernesto Pérez Persona, Mario Arnao, Antoni García-Guiñón, Abel Domingo, Miriam González-Pardo, Javier de la Rubia & María Victoria Mateos. (2023) A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study. Hematology 28:1.
Read now

Articles from other publishers (2)

Ji Hyun Lee, Sung-Hyun Kim, Hye Ryeon Kim, Chang-Ki Min, Je-Jung Lee, Ho-Jin Shin, Jae-Cheol Jo, Ji Yun Lee, Joon Ho Moon & Kihyun Kim. (2022) Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma. International Journal of Hematology 117:2, pages 225-235.
Crossref
. (2022) Multiple drugs. Reactions Weekly 1936:1, pages 353-353.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.